Latest stories on GLMD
Galmed announces name change to Eocene
The Fly50 · neutralgeneral
Galmed Pharmaceuticals Regains Nasdaq Bid-Price Compliance, Avoids Delisting Risk
TipRanks63 · neutralgeneral
Galmed’s New Tissue Assessment Platform Achieves Key Clinical Milestone in Colorectal Surgery Innovation
August 19, 2026
MarketChameleon67 · bullishproduct/pr
Galmed trading halted, news pending
The Fly48 · neutralgeneral
Galmed Reports Aramchol–Xtandi Combo Boosts Prostate Cancer Cell Death in Pre-Clinical Study
TipRanks63 · neutralproduct/pr
Galmed reports results from study of a combination of Aramchol and Xtandi
The Fly59 · neutralproduct/pr
Galmed Unveils High-Exposure Orally Dispersible Aramchol Formulation for Parkinson’s Disease
TipRanks63 · neutralproduct/pr
Galmed Develops Cardiac-Targeted Aramchol Formulation to Expand Cardiovascular Pipeline (NASDAQ:GLMD)
InvestorsHub67 · bullishproduct/pr
Galmed Pharmaceuticals Reports Wider Q1 2026 Loss Amid Higher R&D Spending
TipRanks34 · bearishearnings
Galmed Pharmaceuticals Closes Amended All-Cash Colospan Acquisition With Earnout Structure
TipRanks58 · neutralm&a
Galmed to acquire Colospan in $4.5M deal; shares down
Seeking Alpha54 · neutralm&a
Galmed Pharmaceuticals to Acquire Colospan and Commit $6 Million to European Expansion
TipRanks65 · bullishm&a
Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
PR Newswire68 · bullishm&a
Galmed and Tissue Dynamics Reveal New Metabolic Target for Cardiac Fibrosis With Aramchol Combo
TipRanks63 · neutralproduct/pr